MedPath

GT Medical Technologies, Inc.

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:0
Completed:0

Trial Phases

2 Phases

Phase 3:1
Phase 4:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)โ€ข Click on a phase to view related trials

Phase 4
2 (66.7%)
Phase 3
1 (33.3%)

Post-operative Adjuvant Therapy w/wo GammaTile + Systemic Therapy

Phase 4
Withdrawn
Conditions
Glioblastoma
First Posted Date
2023-06-13
Last Posted Date
2025-04-10
Lead Sponsor
GT Medical Technologies, Inc.
Target Recruit Count
600
Registration Number
NCT05900908

GammaTile and Stupp in Newly Diagnosed GBM

Phase 4
Recruiting
Conditions
Glioblastoma
First Posted Date
2022-04-25
Last Posted Date
2025-05-25
Lead Sponsor
GT Medical Technologies, Inc.
Target Recruit Count
61
Registration Number
NCT05342883
Locations
๐Ÿ‡บ๐Ÿ‡ธ

HonorHeath Scottsdale Osborn Medical Center, Scottsdale, Arizona, United States

๐Ÿ‡บ๐Ÿ‡ธ

Keck Medicine of USC, Los Angeles, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

UC Davis Comprehensive Cancer Center, Sacramento, California, United States

and more 13 locations

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

Recruiting
Conditions
Brain Tumor
Brain Tumor - Metastatic
Brain Tumor, Adult Meningioma
Brain Tumor, Primary
Brain Tumor, Adult: Glioblastoma
Brain Tumor, Recurrent
First Posted Date
2020-06-11
Last Posted Date
2025-02-28
Lead Sponsor
GT Medical Technologies, Inc.
Target Recruit Count
600
Registration Number
NCT04427384
Locations
๐Ÿ‡บ๐Ÿ‡ธ

HonorHeath Scottsdale Osborn Medical Center, Phoenix, Arizona, United States

๐Ÿ‡บ๐Ÿ‡ธ

University of Arkansas Medical Center, Little Rock, Arkansas, United States

๐Ÿ‡บ๐Ÿ‡ธ

Eden Medical Center, Castro Valley, California, United States

and more 45 locations

Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study)

Phase 3
Recruiting
Conditions
Brain Metastases
First Posted Date
2020-04-28
Last Posted Date
2025-07-03
Lead Sponsor
GT Medical Technologies, Inc.
Target Recruit Count
180
Registration Number
NCT04365374
Locations
๐Ÿ‡บ๐Ÿ‡ธ

HonorHeath Scottsdale Osborn Medical Center, Phoenix, Arizona, United States

๐Ÿ‡บ๐Ÿ‡ธ

University of Arkansas Medical Center, Little Rock, Arkansas, United States

๐Ÿ‡บ๐Ÿ‡ธ

Keck Hospital of Usc, Los Angeles, California, United States

and more 35 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

ยฉ 2025 MedPath, Inc. All rights reserved.